Alexander disease: models, mechanisms, and medicine
Alexander disease is a primary disorder of astrocytes caused by gain-of-function mutations in the gene for glial fibrillary acidic protein (GFAP), which lead to protein aggregation and a reactive astrocyte response, with devastating effects on the central nervous system. Over the past two decades si...
Gespeichert in:
Veröffentlicht in: | Current opinion in neurobiology 2022-02, Vol.72, p.140-147 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 147 |
---|---|
container_issue | |
container_start_page | 140 |
container_title | Current opinion in neurobiology |
container_volume | 72 |
creator | Hagemann, Tracy L. |
description | Alexander disease is a primary disorder of astrocytes caused by gain-of-function mutations in the gene for glial fibrillary acidic protein (GFAP), which lead to protein aggregation and a reactive astrocyte response, with devastating effects on the central nervous system. Over the past two decades since the discovery of GFAP as the culprit, several cellular and animal models have been generated, and much has been learned about underlying mechanisms contributing to the disease. Despite these efforts, many aspects of Alexander disease have remained enigmatic, particularly the initiating events in GFAP accumulation and astrocyte pathology, the relation between astrocyte dysfunction and myelin deficits, and the variability in age of onset and disease severity. More recent work in both old and new models has begun to address these complex questions and identify new therapeutics that finally offer the promise of effective treatment. |
doi_str_mv | 10.1016/j.conb.2021.10.002 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8901527</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0959438821001148</els_id><sourcerecordid>2604022381</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-18299078f1a7164df2db1db788683be9b219f7dc9199d76f277de48ec3a08e773</originalsourceid><addsrcrecordid>eNp9kMtKxDAUhoMoOl5ewIXM0oUdc2lzERFk8AaCG12HNDnVDG2jSWfQtzdlVHTjKsnJd_5z-BA6JHhGMOGni5kNfT2jmJJcmGFMN9CESMEKLiXdRBOsKlWUTModtJvSAmPMmWTbaIeVknJelRPELlt4N72DOHU-gUlwNu2CgzadTDuwL6b3qcv3jOS389b3sI-2GtMmOPg699DT9dXj_La4f7i5m1_eF7asqqEgkiqFhWyIEYSXrqGuJq4WUnLJalA1JaoRziqilBO8oUI4KCVYZrAEIdgeuljnvi7rPNtCP0TT6tfoOxM_dDBe__3p_Yt-DistFSYVHQOOvwJieFtCGnTnk4W2NT2EZdKU4xJTyiTJKF2jNoaUIjQ_YwjWo2290KNtPdoea9l2bjr6veBPy7feDJyvgewTVh6iTtZDb7PICHbQLvj_8j8BpcqQWA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2604022381</pqid></control><display><type>article</type><title>Alexander disease: models, mechanisms, and medicine</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Hagemann, Tracy L.</creator><creatorcontrib>Hagemann, Tracy L.</creatorcontrib><description>Alexander disease is a primary disorder of astrocytes caused by gain-of-function mutations in the gene for glial fibrillary acidic protein (GFAP), which lead to protein aggregation and a reactive astrocyte response, with devastating effects on the central nervous system. Over the past two decades since the discovery of GFAP as the culprit, several cellular and animal models have been generated, and much has been learned about underlying mechanisms contributing to the disease. Despite these efforts, many aspects of Alexander disease have remained enigmatic, particularly the initiating events in GFAP accumulation and astrocyte pathology, the relation between astrocyte dysfunction and myelin deficits, and the variability in age of onset and disease severity. More recent work in both old and new models has begun to address these complex questions and identify new therapeutics that finally offer the promise of effective treatment.</description><identifier>ISSN: 0959-4388</identifier><identifier>EISSN: 1873-6882</identifier><identifier>DOI: 10.1016/j.conb.2021.10.002</identifier><identifier>PMID: 34826654</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Alexander Disease - genetics ; Alexander Disease - metabolism ; Alexander Disease - pathology ; Animals ; Astrocytes - metabolism ; Central Nervous System - pathology ; Glial Fibrillary Acidic Protein - genetics ; Glial Fibrillary Acidic Protein - metabolism ; Humans ; Mutation ; Protein Aggregates</subject><ispartof>Current opinion in neurobiology, 2022-02, Vol.72, p.140-147</ispartof><rights>2021 Elsevier Ltd</rights><rights>Copyright © 2021 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-18299078f1a7164df2db1db788683be9b219f7dc9199d76f277de48ec3a08e773</citedby><cites>FETCH-LOGICAL-c455t-18299078f1a7164df2db1db788683be9b219f7dc9199d76f277de48ec3a08e773</cites><orcidid>0000-0002-0237-9267</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.conb.2021.10.002$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34826654$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hagemann, Tracy L.</creatorcontrib><title>Alexander disease: models, mechanisms, and medicine</title><title>Current opinion in neurobiology</title><addtitle>Curr Opin Neurobiol</addtitle><description>Alexander disease is a primary disorder of astrocytes caused by gain-of-function mutations in the gene for glial fibrillary acidic protein (GFAP), which lead to protein aggregation and a reactive astrocyte response, with devastating effects on the central nervous system. Over the past two decades since the discovery of GFAP as the culprit, several cellular and animal models have been generated, and much has been learned about underlying mechanisms contributing to the disease. Despite these efforts, many aspects of Alexander disease have remained enigmatic, particularly the initiating events in GFAP accumulation and astrocyte pathology, the relation between astrocyte dysfunction and myelin deficits, and the variability in age of onset and disease severity. More recent work in both old and new models has begun to address these complex questions and identify new therapeutics that finally offer the promise of effective treatment.</description><subject>Alexander Disease - genetics</subject><subject>Alexander Disease - metabolism</subject><subject>Alexander Disease - pathology</subject><subject>Animals</subject><subject>Astrocytes - metabolism</subject><subject>Central Nervous System - pathology</subject><subject>Glial Fibrillary Acidic Protein - genetics</subject><subject>Glial Fibrillary Acidic Protein - metabolism</subject><subject>Humans</subject><subject>Mutation</subject><subject>Protein Aggregates</subject><issn>0959-4388</issn><issn>1873-6882</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtKxDAUhoMoOl5ewIXM0oUdc2lzERFk8AaCG12HNDnVDG2jSWfQtzdlVHTjKsnJd_5z-BA6JHhGMOGni5kNfT2jmJJcmGFMN9CESMEKLiXdRBOsKlWUTModtJvSAmPMmWTbaIeVknJelRPELlt4N72DOHU-gUlwNu2CgzadTDuwL6b3qcv3jOS389b3sI-2GtMmOPg699DT9dXj_La4f7i5m1_eF7asqqEgkiqFhWyIEYSXrqGuJq4WUnLJalA1JaoRziqilBO8oUI4KCVYZrAEIdgeuljnvi7rPNtCP0TT6tfoOxM_dDBe__3p_Yt-DistFSYVHQOOvwJieFtCGnTnk4W2NT2EZdKU4xJTyiTJKF2jNoaUIjQ_YwjWo2290KNtPdoea9l2bjr6veBPy7feDJyvgewTVh6iTtZDb7PICHbQLvj_8j8BpcqQWA</recordid><startdate>20220201</startdate><enddate>20220201</enddate><creator>Hagemann, Tracy L.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-0237-9267</orcidid></search><sort><creationdate>20220201</creationdate><title>Alexander disease: models, mechanisms, and medicine</title><author>Hagemann, Tracy L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-18299078f1a7164df2db1db788683be9b219f7dc9199d76f277de48ec3a08e773</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Alexander Disease - genetics</topic><topic>Alexander Disease - metabolism</topic><topic>Alexander Disease - pathology</topic><topic>Animals</topic><topic>Astrocytes - metabolism</topic><topic>Central Nervous System - pathology</topic><topic>Glial Fibrillary Acidic Protein - genetics</topic><topic>Glial Fibrillary Acidic Protein - metabolism</topic><topic>Humans</topic><topic>Mutation</topic><topic>Protein Aggregates</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hagemann, Tracy L.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Current opinion in neurobiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hagemann, Tracy L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Alexander disease: models, mechanisms, and medicine</atitle><jtitle>Current opinion in neurobiology</jtitle><addtitle>Curr Opin Neurobiol</addtitle><date>2022-02-01</date><risdate>2022</risdate><volume>72</volume><spage>140</spage><epage>147</epage><pages>140-147</pages><issn>0959-4388</issn><eissn>1873-6882</eissn><abstract>Alexander disease is a primary disorder of astrocytes caused by gain-of-function mutations in the gene for glial fibrillary acidic protein (GFAP), which lead to protein aggregation and a reactive astrocyte response, with devastating effects on the central nervous system. Over the past two decades since the discovery of GFAP as the culprit, several cellular and animal models have been generated, and much has been learned about underlying mechanisms contributing to the disease. Despite these efforts, many aspects of Alexander disease have remained enigmatic, particularly the initiating events in GFAP accumulation and astrocyte pathology, the relation between astrocyte dysfunction and myelin deficits, and the variability in age of onset and disease severity. More recent work in both old and new models has begun to address these complex questions and identify new therapeutics that finally offer the promise of effective treatment.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>34826654</pmid><doi>10.1016/j.conb.2021.10.002</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-0237-9267</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0959-4388 |
ispartof | Current opinion in neurobiology, 2022-02, Vol.72, p.140-147 |
issn | 0959-4388 1873-6882 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8901527 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Alexander Disease - genetics Alexander Disease - metabolism Alexander Disease - pathology Animals Astrocytes - metabolism Central Nervous System - pathology Glial Fibrillary Acidic Protein - genetics Glial Fibrillary Acidic Protein - metabolism Humans Mutation Protein Aggregates |
title | Alexander disease: models, mechanisms, and medicine |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T04%3A20%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Alexander%20disease:%20models,%20mechanisms,%20and%20medicine&rft.jtitle=Current%20opinion%20in%20neurobiology&rft.au=Hagemann,%20Tracy%20L.&rft.date=2022-02-01&rft.volume=72&rft.spage=140&rft.epage=147&rft.pages=140-147&rft.issn=0959-4388&rft.eissn=1873-6882&rft_id=info:doi/10.1016/j.conb.2021.10.002&rft_dat=%3Cproquest_pubme%3E2604022381%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2604022381&rft_id=info:pmid/34826654&rft_els_id=S0959438821001148&rfr_iscdi=true |